Trial · NCT03987711
Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis
NCT03987711, Phase 2, Completed, Unity Health Toronto
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis. Trials, record NCT03987711. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03987711
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Strategies for the Management of Atrial Fibrillation in patiEnts Receiving Dialysis
- NCT number
- NCT03987711
- Status
- Completed
- Phases
- Phase 2
- Enrollment
- 151 participants, actual
- Lead sponsor
- Unity Health Toronto
- Conditions
- Atrial Fibrillation, End Stage Renal Failure on Dialysis
- Interventions
- Warfarin, Apixaban, No oral anticoagulation
- First posted
- 2019-06-17
- Last updated
- 2023-06-22
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Recruitment of the target population within 2 years | 2 years from start of trial | |
| Primary | At least 80% of randomized participants remain in the trial and on the allocated study treatment at the end of the 26-week study period. | 26 weeks | |
| Secondary | Proportion of patients randomized to warfarin achieving a Time in the Therapeutic Range (TTR) >65%. | 26 weeks | |
| Secondary | >95% of randomized patients adhere to the enrollment criteria with respect to atrial fibrillation or atrial flutter | End of trial | Through adjudication of ECGs or other cardiac diagnostics |
| Secondary | Major bleeding | 26 weeks | As defined by the International Society of Thrombosis and Haemostasis (ISTH) |
| Secondary | Clinically relevant non-major bleeding | 26 weeks | As defined by the International Society of Thrombosis and Haemostasis (ISTH) |
| Secondary | Stroke and systemic embolism | 26 weeks | |
| Secondary | All cause mortality | 26 weeks | |
| Secondary | Non-fatal myocardial infarction | 26 weeks | |
| Secondary | Vascular events not related to dialysis access | 26 weeks |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 39495569 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT03987711
GET https://conductscience.org/api/trials/v1/NCT03987711/registered